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Abstract Article Info 
Introduction: The incidence of bone metastases is as much as 20% of all distant metastases in nasopharyngeal 
carcinoma (NPC). However, the publication regarding bone metastasis is limited. 
Case Report: Reported a 58-year-old male patient with a mass on the right upper jugular neck lymph node. 
According to history taking, physical examination, radiology, and histopathology work up, concluded that the 
patients were established as nasopharyngeal cancer with the thoraco-lumbal bone metastasis. The physician 
was starting the chemotherapy; however, due to the advanced stage, this patient was death after the second 
chemotherapy.  
Conclusion: In this article presented a nasopharyngeal carcinoma case with bone metastases that have been 
diagnosed with stage IV B nasopharyngeal carcinoma. This article also described the pathophysiology, 
diagnosis, and treatment of bone metastases in nasopharyngeal carcinoma. 
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1. CASE REPORT 
Reported a 58-year-old male patient who came to the Praya General 
Hospital on January 13, 2019 with the main complaint of a lump in the right neck 
since 8 months ago accompanied by the weakness of the whole body, including 
all four limbs since 3 months ago. In the last 1 month, the complaint slowly began 
to propagate. Three days prior to the hospital visit, the patient could not walk and 
sat, only lying down on the bed. The patient also complained that he could not 
urinate and defecate. He remains could be taking food and water. The lump in 
the neck was initially small and multiple; however, gradually it getting bigger, 
denser, and fixed, without any fever and pain. The other accompanied complaints 
were headache, tinitus, nasal congestion, sometimes accompanied by nasal 
bleeding. There were no complaints such as difficulty when opening the mouth, 
bumps in the armpits and groin, hoarseness, difficulty on breathing, tingling in 
the face, and double vision.  
This patient previously has visited a private practice of ENT 
specialist, and a nasopharyngeal biopsy was done on November 17, 2018. 
CT scan of the head and neck with contrast has been performed with the 
result there is a mass in the nasopharynx. According to those results, the 
patient is advised to the West Nusa Tenggara General Hospital for further 
treatment. Unfortunately, the patient chose alternative medicine until it 
finally comes with a weak condition. 
Based on the history of daily life found that he was a smoker for more 
than 20 years, often consume salted fish and furniture maker. There was no 
history of similar disease or malignancy on the family.  
Physical examination showed a general state was weak, blood pressure 
140/100 mmHg, pulse 88x/minute, respiration rate 20x/minute, temperature 
36.5 o C. Examination of ENT-HN obtained both the external auditory canal 
and eardrum within normal limit. However, the cone of light on the right ear 
was decreased. There was no deformity of the nasal aperture: the nasal 
cavity, inferior turbinate, and middle turbinate and nasal septum within 
normal limits. On throat examination, pharyngeal mucosa, palatum, and 
tonsil within normal limit. There was a mass on the right nasopharynx and 
enlargement of the right upper jugular with the size 8x8x4 cm, solid, fixed, 



















Picture 1. Enlarged lymph nodes on the right upper jugular node 
The neurology examination regarding the eye movement was normal; 
there was no ptosis. The other cranial nerve within normal limits found a 
motoric tetra spastic paresis. Hypesthesia sensibility from toe to C3-4 
dermatome, and there was a vegetative retentio uri et alvi. 
Laboratory work up on 13 January 2019: leucocyte 15.02 k/uL, 
Haemoglobin 11.5 g/dL, platelets 474 k/uL, blood sugar 93 mg/dl. 
Electrolyte Sodium 122 mmol/L, Kalium 4.7 mmol/L, Cloride 87 mmol/L.  
Radiologic examination of the head and neck CT scan with contrast 
appears mass in the right nasopharyngeal extends to the right parafaring. 
Lymphadenopathy right colli with the largest dimension 7.8 cm. 
The treatment is IVFD NaCl 3% 24 drops/minute, cefotaxim 2x1 gram, 
amlodipine 1x10 mg, paracetamol 6x500 mg, codeine 6x10 mg. 
 








Picture 2. Head and neck CT scan with contrast 
On January 15, 2019 patient was referred to West Nusa Tenggara 
General Hospital for CT Scan, staging, and chemoradiotherapy plans. The 
liver function test was examined on 26/1/2019: SGOT 24 u/L, SGPT 10u/L, 
albumin 3.2 mg/dL, Alkaline phosphatase 97.8. Kidney function test 
revealed BUN 24 mg/dl, SC 0.6 mg/dL.  
Thoracolumbar CT scan with contrast was performed on January 24, 
2019. According to this examination found the appearance of lytic lesions 
on the anterior corpus vertebra L2 and vertebra compresi Th10. 
Picture 3. Thoracolumbar CT scan with contrast 
Finally, patients were diagnosed with Nasopharyngeal carcinoma 
Stage IV B (T2N3M1), based on AJCC 8th edition, 2017. The treatment 
was initialized with correcting the general conditions; then the next 
treatment plan was chemotherapy or chemoradiation with platinum-based 
combination through a concurrent technique. On February 6, 2019, first 
cycle chemotherapy was started with paclitaxel 267.75 mg and cisplatin 
122.4 mg. The second chemotherapy was given on March 2, 2019 with 
the similar doses. On March 23, 2019 was planned to the third cycle 
chemotherapy but the patient did not come because he already death on 
March 15, 2019. 
2. DISCUSSION 
Nasopharyngeal carcinoma (NPC) is a malignant tumor that appears in 
the nasopharynx (the area above the throat and behind the nose), especially 
in fossa Rosenmuller and roof nasopharynx which shows evidence of mild 
or ultrastructural microscopic squamous differentiation [2]. 
In Indonesia, NPC is the 4th most malignancy after breast cancer, 
cervical cancer, and lung cancer [3]. In the head and neck area NPC was the 
most prevalence (NPC was composed the 60% of tumors in the head and 
neck area, followed by 18% malignant on nasal and paranasal sinuses, the 
rest 16% were larynx and malignancy of oral cavity tumors, tonsils, 
hypopharynx) [4]. 
Metastases are the growth of cancer into the lymph node and other 
organs, through the lymphogens or hematogenous. Metastases clinically is 
the most important properties of cancer growth and it will altered the 
prognosis [5,6]. 
The percentage of distant metastases in nasopharyngeal cancer (NPC), 
consecutively to pulmonary, bone, liver, kidney, and brain was 20%, 20%, 
10%, 0.4%, 0.4%. The most metastases are on the regional neck node [6].  
The general prognosis of NPC is poor. For stage I, the five years of survival 
rate was 83.7%, stage II 67.9%, and stage III 40.3%, whereas in advanced 
cases with metastases, only around 22.3% [6,7]. 
2.1 Pathophysiology 
Osteoclasts are originated from precursor cells in the monocyte-
macrophage line of the hemopoietic system. Osteoclasts are activated to 
reabsorb the bone and then undergo apoptosis. Cytokines, systemic 
hormones, and conditions around the bone play a role in osteoclast 
formation through the production of macrophage colony-stimulating factors 
and receptor activator of nuclear-kB ligand (RANKL) by stromal cells or 
osteoblasts. RANKL then released by the T cells are activated and expressed 
to the surface by osteoblasts and stromal cells. The function osteoclast was 
to reabsorb bone in normal or pathological conditions by secreting proteases 
that dissolve the bone matrix and produce acids, which release bone 
minerals into the extracellular space below the osteoclast plasma membrane. 
This plasma membrane is directly facing the bone surface. The attachment 
of osteoclasts to the bone surface is very important in the process of bone 
resorption because there is a factors that can inhibit resorption bone like 
cathepsin k. The osteoblast is a cell forming derived bone from mesenchymal 
stem cells. Bone protein is an important factor in stimulating the growth of 
osteoblast to be osteocytes [8]. Cancer cells migrate to the bone 
microenvironment that causes the occurrence activity of osteoclasts to absorb 
bone minerals. Furthermore, the destruction of the cortex bone was initiated. 
The venous system on plexus paravertebral Batson is the main way on the 
spreading of tumor cells to the bone because bone does not have channel 
lymph [9]. Malignant tumors of the head and neck, breast, kidney, and the 
adrenal gland has a relationship with the vertebral venous system so metastases 
bone from this tumor could happen along this vein without through system 
porta, lung and vena cava [10]. 
2.2 Diagnosis 
The diagnosis of bone metastases should be determined based on 
clinical, laboratory, and imaging workup. Definitive diagnosis is 
established by histopathology examination of the organ involved, but it is 
rarely done. Histopathology only in bone metastases lesions where the 
primary lesion is not known. This needs to be done. According to the 
NCCN 2006 version 1:9 if there are radiographic abnormalities in bone 
without pain in patients less than 40 years, then the patient should be 
referred to an orthopedic oncologist for biopsy. For those who up to 40 
years must do the comprehensive workup due to a possibility of a bone 
metastases. A routine bone scan, chest x-ray, pelvic abdominal CT scan, 
must be done. Clinically, the main complaint of bone metastasis usually 
pain. On the circumstances, the neurology disturbance, fracture signs, 
dislocation could be found depends on the location of metastases. On the 
laboratory, exploration may found an enhancement of alkaline 
phosphatase, calcium, and LDH; however, this is not specific.  On 
imaging, a routine bone scanning and X-ray/bone survey should be 
performed. In advanced, in specific cases, the additional examination 
could be performed, such as myelography, CT scan, and MRI [8, 9]. 
2.3 Treatment 
Based on the guideline of the 2018 NCCN in NPC with bone 
metastases, the treatment plan should be a combination of platinum-based 
chemotherapy or chemoradiation with a concurrent technique. The aim of 
radiation therapy on bone metastases is palliative, and it's vital for patients 
with bone pain. However, the radiation depending on the origin of the 
primary tumor. More than three-quarters of the number of patients with 
the pain can be relieved by radiation. Furthermore, the radiation treatment 
on bone metastases is useful to eliminate the pain, prevent the fracture, 
prevent the neurological disturbance, and the final goal is the patient 
could be care ambulatory. The right time to give radiation could prevent 
pathological fracture. In case of fracture, then it should be fixed 
immediately because mechanic pain or bone dislocation will attenuate by 
radiation. Bisphosphonate should be administered as an inhibitor of 
osteoclasts activity, so it could reduce pain symptoms and pathological 
fracture. The medicine should be given to the patient with the results 
abnormal bone scan, photo plain, abnormal CT or MRI. On the other hand, 
if bone lesions are not seen in plain photos or CT/MRI, bisphosphonate 
administration is not recommended [11]. Regular bone scan in 
asymptomatic patients are usually performed on follow-up patients, it is 
not recommended to provide radiation to patients without symptoms 
because the goal of palliative treatment is to relieve symptoms [12]. 
The patient on this case was a 58-year-old male. NPC could be found 
at all ages, but rarely under 20 years. The incidence of NPC began to 
increase at the age of 20-24 years and is often found in the productive age 
of 30-59 years (around 80%) with peaks between 40-49 years [6]. The 
incidence of NPC is higher in men than women with a ratio of 2-3:1 [13].  
In Lombok, the age of the patient with NPC, mostly up to 40 years old (67%) 
with the gender ratio 75% was male [14]. 
This patient also has risk factors related to the etiology of NPC, such as 
active chronic smokers, salted fish consumption history, and as wood dust 
exposure due to furniture employer for a long time. Several studies revealed 
that the risk of NPC in smokers was 30% -100% higher compared to 







nonsmokers [15,16].  Salted fish exposure as a carcinogenic factor at an early 
age are at high risk for the occurrence of NPC [16,17]. The other risk factor is 
Formaldehyde, which is widely used as a solvent, disinfectant, and 
preservative solution [17,18]. Formaldehyde gas (CH2O) is a combustible, 
colorless, and widely used compound in the manufacture of resins, wood 
coatings, photo films, and tissue preservatives. Formaldehyde can irritate the 
eyes and upper respiratory mucosa with a concentration of 0.5-1 ppm [19,20]. 
Another factor is exposure to wood dust that accumulates over a long 
period of time. Wood dust causes irritation and inflammation in the 
nasopharyngeal epithelium, so it could fuse the mucociliary work and may 
change the epithelial cells in the nasopharynx. Exposure to smoke resulting 
from burning firewood and incense smoke for more than 10 years can 
increase the incidence of NPC by about 6 times [19]. 
Epstein Barr Virus (EBV) infected more than 90% of the entire world 
population, but the primary infection of the Epstein Barr virus remains 
inactive and has not shown clinical symptoms [13]. The relationship 
between NPC and Epstein Barr virus was found in 1966 based on the results 
of research in serology through the discovery of EBV DNA and EBV 
nuclear antigen (EBNA) in NPC patients [19]. Genetic factors also take a 
role. The analysis of the relationship between human leukocyte antigen 
(HLA) haplotypes and NPC showed an increased risk in individuals with 
HLA-A2 positive in the Chinese population [13, 20]. 
The main complaint of this patient was the mass in the neck. According 
to the literature, most patients present with complaints of a neck mass. This 
symptom indicated that the patients were coming at an advanced stage (stage 
IV). In the common case, it is difficult to detect early cases of NPC due to 
the hidden nasopharyngeal position; the initial symptoms are not typical like 
the common cold. The process of metastasis in the neck gland is in 
accordance with the flow of lymph from the nasopharynx to the retrofaring 
lymph nodes, which then enter the superior jugular lymph node [3]. 
On examination of the nasopharyngeal biopsy obtained the results of 
undifferentiated carsinoma (WHO type 3). Based on the WHO Head and 
Neck 4th Ed 2017 establishes three forms of nasopharyngeal carcinoma 
histopathology, keratinizing squamous cell carcinoma, non-keratinizing 
squamous cell carcinoma, and basaloid squamous cell carcinoma [21]. 
Keratinizing squamous cell carcinoma, characterized by the 
differentiation of squamous cells with intercellular bridge or keratinization. 
Tumors grow in the form of islands associated with desmoplastic stroma 
with varying infiltration of inflammatory cells such as lymphocytes, plasma 
cells, neutrophils and eosinophils. Tumor cells are polygonal and stratified. 
The boundary between cells is clear and separated by intercellular bridges. 
Cells in the central part of the island show eosinophilic cytoplasm, which 
many sign of keratinization. Keratin pearls are found [21]. 
Non-keratinizing squamous cell carcinoma is characterized by a cell 
that shows clear inter-cell boundaries and sometimes, a faint intercellular 
bridge is found. Compared with undifferentiated carcinoma, the cell size is 
smaller, the ratio of the cytoplasmic nucleus is smaller, the nucleus is more 
hyperchromatic and the core child is not prominent [21]. 
Basaloid squamous cell carcinoma this type has two components, namely 
basaloid cells and squamous cells. Basaloid cells are small with a hyperchromatic 
nucleus, and no nucleus is found and little cytoplasm. Grow in a solid pattern 
with lobular configurations and at some cases, found palisading peripherals. 
Components of squamous cells can be in situ or invasive. The boundary between 
the basaloid and squamous components is clear [21]. 
A CT-Scan with contrast is useful for staging. According to the head 
and neck CT scan obtained tumors located in right nasopharynx expanding 
to the right parafaring, enlargement right colli lymph node with the size 7.8 
cm at level II (jugular superior).  This examination can also determine the 
spread of the tumor to the surrounding tissue which is not too wide, and 
detect base cranii erosion and perineural spread through the foramen ovale 
as intracranial extension to the mainline [22]. 
The enlargement regional lymph nodes indicated that NPC has an 
ability to invaded and related tightly with the lymphoid network. Metastases 
to cervical lymph nodes are commonly found, its occur on 65-86.6% patient. 
Furthermore, this complaint is the often reason that brings the patients to 
seek the medication. The most common location is latero-superior deep 
cervical lymph nodes located just below the mastoid tip, behind the 
mandibular angles, in the medial part of the upper end of the 
sternocleidomastoid muscle, next to mediosuperior deep cervical 
lymphoma. NPC can spread to the lateral retropharyngeal lymph nodes. 
Limfogen metastases pathways are starting from lymphatics, cancer cells 
carried to the station of the first regional lymph nodes through afferent 
channels to a certain place where cancer cells can grow into cancer metastases. 
Then, the cancer cell can reach the next lymph node station [22].               
In determining distant metastases, an examination of lungs, liver, and 
bone was obtained patient with metastases L2 vertebral corpus. According 
to a lumbar CT scan, a lytic lesion is found in the anterior vertebra corpus 
L2, which is suspected bone metastases. Bone metastases may due to the 
hematogenous process. Hematogenous metastases occur when cancer 
cells reach the blood vessels. The penetrated blood vessels determine 
where metastases will occur. If it stops at certain places in the capillary 
area of the circulating cancer cells, it will make a cancer embolism. This 
principle may explain the specific pattern of metastases or specific 
metastatic sites. Nasopharyngeal malignant tumor cells can enter the right 
internal jugular vein or subclavian vein through vasa efferent cervical 
lymph nodes, which then enter the jugular trunk. This spread gives rise to 
distant metastases. Sheng et al. (2007) said that around 5-10% of patients 
with nasopharyngeal carcinoma experience distant metastases [22]. 
Barnes et al .(1996) said that distant metastases is usually preceded by 
locoregional recurrence, but the fact that is found is 10-20% of patients 
who experience distant metastases without locoregional recurrence first 
[23]. Cancer cell migrates to the microenvironment of bone and leads to 
occurrence activity of osteoclasts to absorb bone minerals. If it happens, 
the destruction of the bone cortex will happen. The venous system on 
plexus paravertebral Batson is the main spread of tumor cells to the bone 
because bone does not have channel lymph. Malignant tumors head and 
neck, breast, kidney, and the adrenal gland have a relationship with the 
vertebral venous system. So, bone metastases from this tumor could 
happen along this vein without system porta, lung, and vena cava [24].  
Metastases on the vertebral corpus L2 may cause the symptoms of 
micturition and defecation disturbance. Initially, patients experience urine 
retention and alvi but after the care was given, this symptom is gradually 
improved and patient already could urinate and defecate. The other 
possibility in this condition, it may influence by electrolyte decreases 
(hyponatremia) so the function of the nerve is disturbed, and after corrected, 
all the function has become normal on the next examination. Tetraparesis 
spastic as a consequence existence emphasis on the C 3-4 vertebral corpus 
could not confirm yet from result of the cervical spine CT-Scan examination. 
According to the 2018 guideline of the NCCN, the patient was planned 
to be treated with platinum-based chemotherapy or chemoradiation with a 
concurrent technique [11]. The standard for NPC therapy is radiotherapy. 
The advantage of providing radiotherapy as a single regimen in stage I and 
II cancers will provide 5 years of life expectancy of 90-95%, but the problem 
is most patients come with advanced stages (stage III and IV), some even 
with bad conditions. Aside from NPC is known as a malignancy that has 
high potential to make regional and distant metastases. The success of 
therapy is strongly influenced by the stage; the delay in starting adequate 
treatment may cause the results of therapy to be far from encouraging. 
Another alternative for treating patients with head and neck squamous cell 
carcinoma, which is a locally advanced stage, is induction chemotherapy 
followed by chemoradiotherapy as radical therapy, especially in patients 
with a good response to induction chemotherapy [6, 9]. 
The prognosis of this patient is poor. In these cases, survival is only for 13 
months since the first complaint. In NPC with distant metastases reported that 
five years survival rate is only 22.3%. It was found that type 1 nasopharyngeal 
carcinoma (squamous cell carcinoma) had a worse prognosis than type 2 and 3. 
This may occur due to type 1 is easier to metastases. Overall, the 5-year survival 
rate is 45%. The prognosis is exacerbated by several factors, such as the advanced 
stage, age more than 40 years,  gender, Chinese race than in the white race, an 
enlargement of neck nodes, the presence of cerebral nerve palsy, skull bone 
damage, and distant metastases [6]. 
3. CONCLUSION 
Reported a 58 years old male patient with nasopharyngeal carcinoma 
stage IV B. This patient was planned to be treat as advanced stage 
management. NPC often comes at an advanced stage because symptoms 
were not specific. The location of nasopharyngeal difficult to evaluated 
finally altered the prognosis of the diseases. To prevent other cases in the 
future, the strengthening of early detection in community and primary health 
care facilities becomes important. Furthermore, the physician could increase 
the prognosis. 
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